30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

George Scangos

Track

Insider profile

Currently holds positions in Biogen Inc, Vir Biotechnology Inc, Agilent Technologies Inc and Vir Biotechnology Inc

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
95 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Executive Officer, Director Biogen Inc July 15, 2010 -
Chief Executive Officer, Director Vir Biotechnology Inc None -
Independent Director Agilent Technologies Inc Sept. 17, 2014 -
President, Chief Executive Officer, Director Vir Biotechnology Inc Jan. 1, 2017 -
Independent Director Exelixis Inc July 15, 2010 - May 20, 2020
Chief Executive Officer, Director Vir Biotechnology Inc July 1, 2010 - Dec. 1, 2016
George Scangos's trades of Vir Biotechnology Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-11 2025-06-11
PrS Proposed sale
77,652
87.55
US$4,090,963 		77,652 87.55 US$4,090,963
2025-06-10 2025-06-10
PrS Proposed sale
80,932
305.76
US$1,169,993 		80,932 305.76 US$1,169,993
2025-06-09 2025-06-09
PrS Proposed sale
72,848
315.96
US$2,979,960 		72,848 315.96 US$2,979,960
2025-02-25 2025-02-24
S Sale
10,056 -1.4%
9.45
US$95,063 		10,056 -1.4% 9.45 US$95,063
2025-02-24 2025-02-24
PrS Proposed sale
10,056
9.45
US$95,063 		10,056 9.45 US$95,063
2025-02-19 2025-02-18
S Sale
10,964 -1.5%
9.81
US$107,575 		10,964 -1.5% 9.81 US$107,575
2025-02-18 2025-02-18
PrS Proposed sale
10,964
9.81
US$107,575 		10,964 9.81 US$107,575
2024-02-26 2024-02-26
PrS Proposed sale
17,722
11.53
US$204,335 		17,722 11.53 US$204,335
2024-02-26 2024-02-26
PlS Planned sale
17,722 -13.6%
11.65
US$206,522 		17,722 -13.6% 11.65 US$206,522
2024-02-26 2024-02-22
S Sale
10,028 -7.1%
10.05
US$100,737 		10,028 -7.1% 10.05 US$100,737
2024-02-20 2024-02-20
PrS Proposed sale
16,872
10.25
US$172,938 		16,872 10.25 US$172,938
2024-02-20 2024-02-20
PlS Planned sale
16,872 -10.7%
10.22
US$172,385 		16,872 -10.7% 10.22 US$172,385
2024-02-20 2024-02-16
S Sale
10,878 -6.5%
10.24
US$111,386 		10,878 -6.5% 10.24 US$111,386
2023-02-24 2023-02-24
PlS Planned sale
10,880 -6.1%
23.56
US$256,300 		10,880 -6.1% 23.56 US$256,300
2023-02-24 2023-02-24
PlS Planned sale
4,239 -2.3%
22.74
US$96,382 		4,239 -2.3% 22.74 US$96,382
2023-02-24 2023-02-23
S Sale
12,631 -6.4%
25.97
US$328,065 		12,631 -6.4% 25.97 US$328,065
2023-02-21 2023-02-21
PlS Planned sale
6,474 -3.2%
28.80
US$186,451 		6,474 -3.2% 28.80 US$186,451
2023-02-21 2023-02-21
PlS Planned sale
11,382 -5.3%
28.02
US$318,867 		11,382 -5.3% 28.02 US$318,867
2023-02-21 2023-02-17
S Sale
9,894 -4.4%
25.29
US$250,199 		9,894 -4.4% 25.29 US$250,199
2022-02-22 2022-02-18
PlS Planned sale
17,726 -13.6%
30.65
US$543,304 		17,726 -13.6% 30.65 US$543,304
2022-02-22 2022-02-17
S Sale
10,024 -7.1%
31.93
US$320,074 		10,024 -7.1% 31.93 US$320,074
2020-05-20 2020-05-18
US Exelixis Inc (EXEL)
PlS Planned sale
75,000 -9.5%
25.96
US$1,947,000 		75,000 -9.5% 25.96 US$1,947,000
2020-04-24 2020-04-24
US Exelixis Inc (EXEL)
PlS Planned sale
15,000 -2.0%
26.24
US$393,600 		15,000 -2.0% 26.24 US$393,600
2020-04-24 2020-04-23
US Exelixis Inc (EXEL)
PlS Planned sale
55,700 -6.9%
26.23
US$1,461,011 		55,700 -6.9% 26.23 US$1,461,011
2020-04-24 2020-04-23
US Exelixis Inc (EXEL)
PlS Planned sale
44,300 -5.2%
25.68
US$1,137,624 		44,300 -5.2% 25.68 US$1,137,624
2020-04-22 2020-04-22
US Exelixis Inc (EXEL)
PlS Planned sale
4,200 -0.5%
25.05
US$105,210 		4,200 -0.5% 25.05 US$105,210
2020-04-22 2020-04-21
US Exelixis Inc (EXEL)
PlS Planned sale
5,800 -0.7%
25.04
US$145,232 		5,800 -0.7% 25.04 US$145,232
2020-04-22 2020-04-20
US Exelixis Inc (EXEL)
PlS Planned sale
5,900 -0.7%
24.70
US$145,730 		5,900 -0.7% 24.70 US$145,730
2020-04-22 2020-04-20
US Exelixis Inc (EXEL)
PlS Planned sale
25,600 -2.9%
24.07
US$616,192 		25,600 -2.9% 24.07 US$616,192
2020-04-22 2020-04-20
US Exelixis Inc (EXEL)
PlS Planned sale
18,500 -2.0%
23.39
US$432,715 		18,500 -2.0% 23.39 US$432,715
2020-04-17 2020-04-15
US Exelixis Inc (EXEL)
PlS Planned sale
25,000 -2.7%
18.31
US$457,750 		25,000 -2.7% 18.31 US$457,750
2020-04-09 2020-04-08
US Exelixis Inc (EXEL)
PlS Planned sale
7,065 -0.7%
18.35
US$129,643 		7,065 -0.7% 18.35 US$129,643
2020-04-09 2020-04-07
US Exelixis Inc (EXEL)
PlS Planned sale
16,435 -1.7%
18.25
US$299,939 		16,435 -1.7% 18.25 US$299,939
2020-04-02 2020-03-31
US Exelixis Inc (EXEL)
PlS Planned sale
1,500 -0.2%
18.06
US$27,090 		1,500 -0.2% 18.06 US$27,090
2020-02-21 2020-02-18
US Exelixis Inc (EXEL)
PlS Planned sale
50,000 -4.9%
20.73
US$1,036,500 		50,000 -4.9% 20.73 US$1,036,500
2020-02-12 2020-02-12
US Exelixis Inc (EXEL)
PlS Planned sale
21,000 -2.0%
20.02
US$420,420 		21,000 -2.0% 20.02 US$420,420
2020-02-12 2020-02-11
US Exelixis Inc (EXEL)
PlS Planned sale
4,000 -0.4%
20.14
US$80,560 		4,000 -0.4% 20.14 US$80,560
2020-01-24 2020-01-22
US Exelixis Inc (EXEL)
PlS Planned sale
25,000 -2.4%
19.75
US$493,750 		25,000 -2.4% 19.75 US$493,750
2020-01-17 2020-01-15
US Exelixis Inc (EXEL)
PlS Planned sale
25,000 -2.3%
20.39
US$509,750 		25,000 -2.3% 20.39 US$509,750
2019-07-03 2019-07-01
US Exelixis Inc (EXEL)
PlS Planned sale
40,000 -3.3%
21.58
US$863,200 		40,000 -3.3% 21.58 US$863,200
2019-06-05 2019-06-04
US Exelixis Inc (EXEL)
PlS Planned sale
15,000 -1.2%
20.00
US$300,000 		15,000 -1.2% 20.00 US$300,000
2019-06-05 2019-06-03
US Exelixis Inc (EXEL)
PlS Planned sale
25,000 -2.0%
19.61
US$490,250 		25,000 -2.0% 19.61 US$490,250
2019-05-03 2019-05-02
US Exelixis Inc (EXEL)
PlS Planned sale
15,000 -1.2%
20.00
US$300,000 		15,000 -1.2% 20.00 US$300,000
2019-05-03 2019-05-01
US Exelixis Inc (EXEL)
PlS Planned sale
25,000 -2.0%
19.75
US$493,750 		25,000 -2.0% 19.75 US$493,750
2019-04-03 2019-04-03
US Exelixis Inc (EXEL)
PlS Planned sale
5,000 -0.4%
25.03
US$125,150 		5,000 -0.4% 25.03 US$125,150